Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinica...(cal industry said Mr Lim co-chair of the...)

Date:10/19/2007

cal industry, said Mr Lim, co-chair of the BMS EXCO. We thank Sir Richard Sykes and the IAC members for their invaluable advice and guidance and for journeying with us since 2000. Moving forward, the BMS EXCO will continue to strengthen the basic research capabilities as it strongly supports clinical research and clinical trials with the necessary capabilities, talent and infrastructure.

Ms Yong Ying-I, Permanent Secretary (Ministry of Health) and co-chair of the BMS EXCO says: These latest initiatives are core to our efforts to strengthen and better integrate our research and clinical capabilities at the Outram and Kent Ridge medical campuses which will ultimately benefit our patients. Our scientists and clinicians are excited by the opportunity these initiatives provide them to participate actively in TCR at the national level. Our healthcare leaders found the discussions with the IAC most valuable, as they have used their experience and expertise to guide and challenge our thinking as to the next level of excellence we can attain.

I have been involved with the Biomedical Sciences efforts in Singapore for the last 7 years. I have to say that what has been achieved during this period is nothing short of spectacular success, commended Sir Richard Sykes who has chaired the BMS IAC since it was set up in 2000. The success includes the building of Biopolis, the state of the art facilities and equipment, the gathering of some of the finest international and local scientists, and very importantly, the young scientific talents that have been nurtured. What is particularly meaningful for me as Chairman of the IAC, and I believe I also speak for all members of the IAC, is to witness and feel that you are a part of this progress. You see the follow through from the discussion and advice that you offer, year after year. I just want to add that, having spent more than thirty years in the pharmaceutical industry, in order to build a vibrant and
'/>"/>

Contact: Janet Low janet_low@a-star.edu.sg 656-826-6337 Agency for Science, Technology and Research (A*STAR), Singapore Source:Eurekalert

0 GOOD

Page: 1 2 3 4 5 6
Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. Worlds largest rainforest drying experiment completes first phase
3. Kinovate Life Sciences Launches Nittophase?High Performance Solid Support For Oligonucleatide Synthesis
4. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
5. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
6. Ebola DNA vaccine produces immune responses in all fully vaccinated volunteers in Phase 1 trial
7. NIH announces phase III clinical trial of creatine for Parkinsons disease
8. Automatic extraction of gene/protein biological functions from biomedical text
9. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
10. Scientists create digital bacteria to forge advances in biomedical research
11. Boston University biomedical engineers win major grant for pursuit of the $1,000 Genome